Aggarwal Sumit

CIK 00018543621 companyARLINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001854362

Recent Transactions

33 trades

Award
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2026-06-10+328,833→ 328,833 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Common Stock
2026-02-28$0.15/sh+260,946→ 1,672,756 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2026-02-28−260,946→ 3,336,144 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Common Stock
2026-01-24+15,000→ 1,411,810 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Restricted Stock Units
2026-01-24−15,000→ 15,000 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Common Stock
2025-09-19+1,000,000→ 1,396,810 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2025-09-19+3,597,090→ 3,597,090 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Common Stock
2025-08-14$0.00/sh+196,880→ 396,810 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2025-08-14−60,390→ 0 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2025-08-14−68,700→ 0 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2025-08-14−25,000→ 0 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2025-08-14−42,790→ 0 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Restricted Stock Units
2025-01-24−30,000→ 30,000 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Common Stock
2025-01-24+30,000→ 199,930 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Common Stock
2024-10-16+165,000→ 169,930 total
Disposition to Issuer
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2024-10-16−42,790→ 0 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2024-10-16+42,790→ 42,790 total
Disposition to Issuer
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2024-10-16−35,580→ 0 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2024-10-16+35,580→ 35,580 total
Disposition to Issuer
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2024-10-16−24,810→ 0 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2024-10-16+24,810→ 24,810 total
Disposition to Issuer
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2024-10-16−68,700→ 0 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2024-10-16+68,700→ 68,700 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Restricted Stock Units
2024-01-24+60,000→ 60,000 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Options (Right to Buy)
2023-01-25+68,700→ 68,700 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Option (Right to Buy)
2022-02-06+42,790→ 42,790 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Restricted Stock Units
2021-12-01−279,158→ 0 total
Tax Payment
Eloxx Pharmaceuticals, Inc.$ELOX
Common Stock
2021-12-01$0.72/sh−81,933→ 197,225 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.$ELOX
Common Stock
2021-12-01+279,158→ 279,158 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Options (Right to Buy)
2021-05-18+992,409→ 992,409 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Restricted Stock Units
2021-04-01+55,854→ 279,158 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Restricted Stock Units
2021-04-01+223,304→ 223,304 total
Award
Eloxx Pharmaceuticals, Inc.$ELOX
Stock Options (Right to Buy)
2021-04-01+1,423,238→ 1,423,238 total

Companies

Eloxx Pharmaceuticals, Inc.
Director, President and CEO
$ELOX

Recent Filings

Address

C/O ELOXX PHARMACEUTICALS, INC. P.O. BOX 274

ARLINGTON, MA, 02476

View on SEC.gov